Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of A Reduced Dexamethasone Pre-Medication Dose in Elderly Patients Treated With Weekly Docetaxel

NCT00215748 is registered in ClinicalTrials.gov with Geriatric Oncology Consortium as lead sponsor.

NCT NCT00215748
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00215748 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of A Reduced Dexamethasone Pre-Medication Dose in Elderly Patients Treated With Weekly Docetaxel
Lead sponsor
Geriatric Oncology Consortium
Phase
Phase 2
Overall status
Terminated
Start date
August 31, 2004
Completion date
April 30, 2007
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, lung cancer